Anthera Pharmaceuticals Inc Stock Nasdaq
Equities
US03674U2015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Sales 2016 | 0.14 0.2 | Sales 2017 | - | Capitalization | 22.85M 31.26M |
---|---|---|---|---|---|
Net income 2016 | -55M -75.23M | Net income 2017 | -26M -35.56M | EV / Sales 2016 | 44,069,434 x |
Net cash position 2016 | 20.84M 28.51M | Net cash position 2017 | 2.2M 3M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 116B | |
+12.35% | 106B | |
-8.37% | 23.89B | |
-2.56% | 21.58B | |
-10.67% | 18.96B | |
-40.50% | 16.96B | |
-13.69% | 16.33B | |
+6.61% | 14.14B | |
+32.96% | 12.02B |